韦敏燕,女,中山大学药剂学博士,广州医科大学药学院药剂教研室副教授,硕士研究生导师,广州市高层次人才青年后备(2020年)。1984年10月生于广西。2007年毕业于湖北中医药大学药物制剂专业,获理学学士学位。同年考入中山大学药学院药剂学专业攻读硕士学位,2009年获硕博连读资格,直接攻读药剂学博士。2012年6月毕业于中山大学药学院药剂专业,获理学博士学位。2012年7月入职广州医科大学药学院药学系工作。中国药理学会表观遗传药理学专业委员会委员。主要从事药剂学教学和科研工作。熟悉新药开发技术,参与并完成了多项企业的新药开发研究项目。近年来一直围绕仿生、靶向纳米给药系统和“和药”广陈皮的药效基础及其制剂开发等领域开展研究工作,先后主持国家自然科学基金青年项目1项,广东省基础与应用基础研究基金省企联合基金面上项目1项,广东省基础与应用基础研究基金青年提升项目1项,广东省自然科学基金博士启动项目1项,教育部协同育人项目1项,广东省教育规划项目1项,广州市高等教育项目1项。参与国家自然科学基金面上项目等国家级课题4项。在Acta Pharmacologica Sinica, Journal of Nanobiotechnology, Materials Science and Engineering C, International Journal of Nanomedicine, LWT-Food Science and Technology等国内外期刊发表论著三十余篇,申请专利4项,其中获授权专利2项。
主讲课程:药剂学(本科)、药剂学实验(本科)
研究方向:新技术与新剂型
荣誉:
广州市高层次人才青年后备(2020年)
广东省首届本科高校课程思政教学大赛农医组三等奖(2021年)
近年来主持或参与的课题有:
1. 科研项目
[1] 广东省自然科学基金青年提升项目,2024A1515030229,“和药”陈皮有效单体川陈皮素仿生纳米酶的构建及其靶向调控药源性肝损伤微环境的机制研究,2024/01-2026/12,30万元,在研,主持
[2] 广东省基础与应用基础研究基金省企联合基金面上项目,2021A1515220188,基于《中国药典》(2020年版)标准的陈皮及其组方二陈汤新配方颗粒的制备工艺、质量标准、药效学及作用机制研究,2021/11-2024/10,40万元,在研,主持
[3] 国家自然科学基金青年科学基金项目,81402881,ASGPR介导的pH敏感型肝癌靶向载药磁性脂质纳米粒的构建及其对肝癌MRI可视化靶向治疗的研究,2015/01 -2017/12,23万元,已结题,主持
[4] 国家自然科学基金青年基金项目,81803463,基于细胞毒性药物5-FU在肿瘤局部产生原理的前药代谢酶基因CDUPRT脂质体用于乳腺癌靶向化疗,2019/01-2021/12,21万元,已结题,参与
[5] 国家自然科学基金-广东联合重点项目,U1601227,CPCs对单核/巨噬细胞表型转换的重编程调控及其逆转心脏纤维化重构的机构研究,2017/01-2020/12,240万元,已结题,参与
[6] 国家自然科学基金面上项目,81573575,久咳要药五味子治疗慢性咳嗽高敏综合征的药效物质基础及药理机制研究,2016/01 -2019/12,64.5万元,已结题,参与
[7] 国家自然科学基金面上项目,81571665,多功能智能化MR纳米探针的构建及肝癌诊疗一体化实验研究,2016/01 -2019/12,71.84万元,已结题,参与
[8] 广东省自然科学基金博士启动项目,S2012040014348,ASGPR介导的双载药肝癌靶向脂质体的构建及其联合化疗抗肿瘤作用的研究,2013/10 -2015/10,3万元,已结题,主持
[9] 广州医科大学科研基金博士启动项目,2012C74,乳铁蛋白修饰的肝癌靶向脂质体给药系统的研究,2012/11 -2015/11,1万元,已结题,主持
2. 教改项目
[1] 教育部高等教育司产学合作协同育人项目,教育司函[2020]6号:201902114006,基于“速课网”的移动信息化药剂学混合式教学平台的建立,2021/01-2021/12,6万元,已结题,主持
[2] 广东省教育科学“十三五”规划研究项目,2020GXJK397,以制剂创新思维为导向的“理论-实验-实践”三维一体化药剂学云教学平台的构建及其混合式教学模式探索,2021/01-2022/12,1万元,已结题,主持
[3] 广州市高等教育教学改革项目,基于“中国药学好故事”的药剂学混合式课程思政教学模式的构建与探索,2022/01-2024/12,2万元,在研,主持
[4] 广州医科大学2021年教学质量与教学改革工程项目,基于“中国药学好故事”的药剂学混合式课程思政教学模式的构建与探索,2022/01-2024/12,1.5万元,在研,主持
[5] 广州医科大学教育科学“十二五”规划课题实验教学改革项目,生物药剂学与药物动力学综合实验教学体系的建立与实践,2013/01 -2014/12,0.3万元,已结题,主持
代表性论著:
1. Jinrong Ning#, Guodong Zheng#, Yi Cai#, Yunguang Hu, Yiqi Liu, Enping Lai, Baizhong Chen, Yujie Liu, Ziqi Liang, Jijun Fu*, Minyan Wei*. The self-assembly Soluplus nanomicelles of nobiletin in aqueous medium based on solid dispersion and their increased hepatoprotective effect on APAP-induced acute liver injury. International Journal of Nanomedicine, 2023,18:5119-5140. (IF:8.0)
2. Jionghua Huang#, Chuangjia Huang#, Yu Lina#, Xiaoling Guan, Shangwen Liang, Li Jianhong, Lu Liang*, Minyan Wei*, Lingmin Zhang*. Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis. Acta Pharmacologica Sinica, 2023, 44(10):1962-1976. (IF:8.2)
3. Guodong Zheng#, Kanghui Wang#, Baizhong Chen, Mengshi Liu, Wanling Yang, Jinrong Ning, Yi Cai*, Minyan Wei*. The enhanced solubility and anti-lipase activity of citrus peel polymethoxyflavonoids extracts with liposomal encapsulation, LWT - Food Science and Technology, 2022, 161, 113395. (IF: 6.0)
4. Jinrong Ning#, Kanghui Wang#, Wanling Yang, Mengshi Liu, Jingyuan Tian, Minyan Wei*, Guodong Zheng*. Qualitative and quantitative analyses of chemical components of Citri Sarcodactylis Fructus from different origins based on UPLC-Q-Exactive Orbitrap-MS and GC-MS, Food Science & Nutrition, 2022, 10(6):2057-2070. (IF: 3.9)
5. Yingxin Chao#, Eyu Tan#, Shaofeng Ma, Baizhong Chen, Mengshi Liu, Kanghui, Wang, Wanling Yang, Minyan Wei*, Guodong Zheng*. Dynamic variation of the phytochemical and volatile compounds in the pericarp of Citrus reticulata ''Chachi'' (Rutaceae) during 2 years of storage, Journal of Food Science, 2022, 87:153-164. (IF: 3.9)
6. Mengshi Liu#, Kanghui Wang#, Baizhong Chen, Yi Cai, Chuwen Li, Wanling Yang, Minyan Wei*, Guodong Zheng*. Intraspecific DNA Barcoding and Variation Analysis for Citri Reticulatae Pericarpium of Citrus reticulata “Chachi”, Evidence-Based Complementary and Alternative Medicine, 2021, 2609935. (IF: 2.650)
7. Chuangjia Huang#, Xiaoling Guan#, Hui Lin#, Lu Liang, Yingling Miao, Yueheng Wu, Huiqiong Bao, Xiaodan Wu, Ao Shen*, Minyan Wei*, Jionghua Huang*. Efficient photoacoustic imaging with biomimetic mesoporous silica-based nanoparticles, Frontiers in Bioengineering and Biotechnology, 2021, 762956. (IF: 5.7)
8. Jijun Fu#; Chuwen Li#; Yang Liu#; Mingyue Chen; Qiang Zhang; Xiyong Yu; Bo Wu; Jiexia Li; Lingran Du; Yuanye Dang; Dan Wu; Minyan Wei*; Zhiqiang Lin*; Xueping Lei*. The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer, Journal of Nanobiotechnology, 2020, 18(1):146. (IF: 10.2)
9. Minyan Wei#, Xueping Lei#, Jingjing Fu#, Mingyue Chen, Jiexia Li, Xiyong Yu, Yinlei Lin, Jingping Liu, Lingran Du, Xin Li, Yu Zhang, Yingling Miao, Yugang Huang*, Lu Liang*, Jijun Fu*. The use of amphiphilic copolymer in the solid dispersion formulation of nimodipine to inhibit drug crystallization in the release media: Combining nano-drug delivery system with solid preparations. Materials Science and Engineering C-Materials for Biological Applications, 2020, 111:110836. (IF: 7.9)
10. Guodong Zheng#, Yingxin Chao#, Mengshi Liu, Yuhua Yang, Dedong Zhang, Kanghui Wang, Yiwen Tao, Jianye Zhang, Yongmei Li*, Minyan Wei*. Evaluation of dynamic changes in the bioactive components in Citri Reticulatae Pericarpium (Citrus reticulata ‘Chachi’) under different harvesting and drying conditions. Journal of the Science of Food and Agriculture, 2021, 101, 8: 3280-3289. (IF: 4.1)
11. Guodong Zheng, Xiujuan Yang, Baizhong Chen, Yingxin Chao, Pingjun Hu, Yi Cai, Bo Wu*, Minyan Wei*. Identification and determination of chemical constituents of Citrus reticulata semen through ultra high performance liquid chromatography combined with Q Exactive Orbitrap tandem mass spectrometry. Journal of Separation Science, 2020, 43(2):438-451. (IF:3.1)
12. Guodong Zheng, Yingxin Chao, Meixia Luo, Bin Xie, Dedong Zhang, Pingjun Hu, Xiujuan Yang, Depo Yang*, Minyan Wei*. Construction and Chemical Profile on “Activity Fingerprint” of Citri Reticulatae Pericarpium from Different Cultivars Based on HPLC-UV, LC/MS-IT-TOF, and Principal Component Analysis. Evidence-Based Complementary and Alternative Medicine. 2020, 2020: 4736152. (IF:2.65)
13. Guodong Zheng, Xiujuan Yang, Mengshi Liu, Yingxin Chao, Baizhong Chen, Depo Yang,* Minyan Wei*. Supercritical CO2 Fluid Extraction for the Identification of Compounds from Citrus reticulata Semen by Ultra-High-Performance Liquid Chromatography Combined with Q-Exactive Orbitrap Tandem Mass Spectrometry. ACS Omega, 2020, 5(5):2180-2186. (IF:4.1)
14. Guodong Zheng, Mengshi Liu, Yingxi Cao, Yuhua Yang, De dong Zhang, Yiwen Tao, Jianye Zhang, Caifang Zeng*, Minyan Wei*. Identification of lipophilic components in Citri Reticulatae Pericarpium cultivars by supercritical CO2 fluid extraction with ultra-high-performance liquid chromatography–Q Exactive Orbitrap tandem mass spectrometry. Journal of separation science, 2020, 6: 1-20. (IF:3.1)
15. Minyan Wei, Xiucai Guo, Liuxiao Tu, Qi Zou, Qi Li, Chenyi Tang, Bao Chen, Yuehong Xu*, Chuanbin Wu*. Lactoferrin modified PEGylated liposomes loaded with doxorubicin for targeting delivery of hepatocellular carcinoma. International Journal of Nanomedicine, 2015, 10:5123-5137. (IF: 8.0)
16. Minyan Wei, Yuehong Xu*, Qi Zou, Liuxiao Tu, Chenyi Tang, Ting Xu, Lihe Deng, Chuanbin Wu*. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. European Journal of Pharmaceutical Sciences, 2012, 46 (3):131-141. (IF: 4.6)
授权专利:
1. 郑国栋、韦敏燕、蔡轶、王康慧、宁金容、杨婉玲、刘梦诗(广州医科大学).一种多甲氧基黄酮脂质体及其制备方法,授权时间:2023-2-3,中国,专利号:ZL 202210111968.6
2. 郑国栋、刘鄂湖、韦敏燕(广州医科大学). 一种多甲氧基黄酮、组合物及其制剂用于预防或治疗糖尿病的用途,授权时间:2019-3-15,中国,专利号:ZL 201610827938.X